[1] Kooperkamp H, Mehta I, Fary D, et al. Pulmonary thromboendarterectomy for pulmonary hypertension before considering transplant[J]. Ochsner J, 2017, 17(1):66-70. [2] Reddy YN, Melenovsky V, Redfield MM, et al. High-output heart failure:a 15-year experience[J]. J Am Coll Cardiol, 2016, 68(5):473-482. [3] Talwar A, Sahni S, Verma S, et al. Exercise tolerance improves after pulmonary rehabilitation in pulmonary hypertension patients[J]. J Exerc Rehabil, 2017, 13(2):214-217. [4] Opitz CF, Hoeper MM, Gibbs JS, et al. Pre-capillary, combined, and post-capillary pulmonary hypertension:apathophysiological continuum[J]. J Am Coll Cardiol, 2016, 68(4):368-378. [5] 朱阿楠, 王淑君, 王园园, 等. p38-MAPK信号通路在HHPH中的作用及三七总皂苷干预[J]. 中国应用生理学杂志, 2012, 28(1):79-84. [6] Zhang H, Chang H, Wang LM, et al. Effect of polyelectrolyte film stiffness on endothelial cells during endothelial-to-mesenchymal transition[J]. Biomacromolecules, 2015, 16(11):3584-3593. [7] Lin F, Wang N, Zhang TC. The role of endothelial-mesenchymal transition in development and pathological process[J]. IUBMB Life, 2012, 64(9):717-723. [8] AktugDemir N, Kolgelier S, Inkaya AC, et al. Are bone morphogenetic protein-7(BMP-7) serum levels correlated with development of hepatic fibrosis[J]? J Infect Dev Ctries, 2014, 8(5):605-610. [9] Mason RM. Fell-Muir lecture:connective tissue growth factor (CCN2)——a pernicious and pleiotropic player in the development of kidney fibrosis[J]. Int J Exp Pathol, 2013, 94(1):1-16. [10] 赵美平, 缪初蕾, 张聪聪, 等. 川芎嗪注射液对慢性阻塞性肺疾病患者肺动脉高压的作用及其机制[J]. 中国应用生理学杂志, 2016, 32(5):408-412. [11] DuBrock HM, Kradin RL, Rodriguez-Lopez JM, et al. Pulmonary capillary hemangiomatosis:the role of invasive cardiopulmonary exercise testing[J]. Pulm Circ, 2015, 5(3):580-586. [12] 许益笑, 王园园, 贾旭广, 等. 内源性硫化氢体系与低O2高CO2性肺动脉高压的相关性研究[J]. 中国应用生理学杂志, 2011, 27(3):300-304. [13] Ogawa E, Hori T, Doi H, et al. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension:Kyoto University experience[J]. Clin Transplant, 2014, 28(9):1031-1040. [14] Ali MA, Tazmin T, Latif T, et al. Incomplete pentalogy of cantrell——acase report[J]. Mymensingh Med J, 2016, 25(1):153-157. [15] Bajwa AA, Shujaat A, Patel M, et al. The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease[J]. PulmCirc, 2017, 7(1):82-88. [16] Lee JC, Kim KC, Choe SY, et al. Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazinetreatment. Anat Cell Biol, 2016, 49(1):7-14. [17] Roden AC, Yi ES. Pulmonary Langerhans cell histiocytosis:an update from the pathologists' perspective[J]. Arch Pathol Lab Med, 2016, 140(3):230-240. [18] Suratt BT, Ubags NDJ, Rastogi D, et al. An official American thoracic society workshop report:obesity and metabolism. An emerging frontier in lung health and disease[J]. Ann Am ThoracSoc, 2017, 14(6):1050-1059. [19] Masumoto K, de Rooij JD, Suita S, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development[J]. Histopathology, 2015, 47(4):410-419. [20] 王淑君, 刘立宾, 黎关龙, 等. 三七皂苷单体R1抑制低氧高CO2诱导的肺动脉平滑肌细胞p38MAPK信号通路的活化[J]. 中国病理生理杂志, 2012, 28(1):105-108. [21] Vasuri F, Resta L, Fittipaldi S, et al. RUNX-1 and CD44 as markers of resident stem cell derivation in undifferentiated intimal sarcoma of pulmonary artery[J]. Histopathology, 2012, 61(4):737-743. [22] Han C, Hong KH, Kim YH, et al. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension[J]. Hypertension, 2013, 61(5):1044-1052. [23] Kitao A, Sato Y, Sawada-Kitamura S, et al. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension[J]. Am J Pathol, 2009, 175(2):616-626. [24] 刘雅洁, 孙小涵, 王洪海. 肺胀病的源流考及治法方药探析[J]. 中医临床研究, 2016, 8(10):37-39. [25] 黄礼明. 试论痰、瘀、虚与COPD辨治关系[J]. 贵阳中医学院学报, 2000, 22(1):5. |